Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- GAP -14.7%, ESTC -10.8%, AEO -6.9%, NTAP -5.4%, COO -5%, PD -4.9%, MRVL -3.4%
Other news:
- NMAX -7.5% (renewal agreement on Verizon Fios service)
- EOSE -7.2% (prices offering of 18.75 mln shares of common stock at $4.00 per share)
- RGTI -5.4% (entered into $350 mln Open Market Sale Agreement)
- SNY -4.5% (reports Itepekimab met the primary endpoint in one of two COPD phase 3 studies)
- TATT -3.6% (prices public offering and secondary offering of 4.15 mln ordinary shares at 26.00 per share)
- SMMT -3.5% (Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer after EGFR TKI Therapy in Global Study)
- SMR -2.7% (NuScale reactor achieves standard design approval from US Nuclear Reg Commission)
- INGR -1.9% (INGR and AMRS) wind down RealSweet JV)
- PLMR -1.2% (completes reinsurance placement; also guides)
- TWO -1.1% (to record a contingency liability)
- CWT -1.1% (signs agreements)